Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2020 Nov;46(11):2089-2091.
doi: 10.1007/s00134-020-06235-8. Epub 2020 Sep 14.

The pooled prevalence of pulmonary embolism in patients with COVID-19

Li Shi  1 , Jie Xu  1 , Guangcai Duan  1 , Haiyan Yang  2 , Yadong Wang  3
Affiliations
Comment

The pooled prevalence of pulmonary embolism in patients with COVID-19

Li Shi et al. Intensive Care Med. 2020 Nov.
No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no any potential conflict of interest regarding this submitted manuscript.

Figures

Fig. 1
Fig. 1
a Forest plot of the pooled prevalence and its 95% confidence interval (CI) for pulmonary embolism (PE) among coronavirus disease 2019 (COVID-19) patients showed that there was a relatively high prevalence of PE (8%, 95% CI 6–11%; χ2 = 1259.68, P < 0.01; I2 = 95.95%) in COVID-19 patients; b Forest plot of the pooled prevalence and its 95% CI for PE among the patients undergoing PE diagnosis showed that the pooled prevalence of PE in patients undergoing PE diagnosis was as high as 28% (95% CI 22–34%; χ2 = 429.11, P < 0.01; I2 = 93.71%); c The pooled prevalence of PE (19%, 95% CI 14–25%; χ2 = 346.07, P < 0.01; I2 = 92.49%) in COVID-19 patients admitted to intensive care unit (ICU) was significantly higher than (d) The pooled prevalence of PE (9%, 95% CI 6–13%; χ2 = 379.37, P < 0.01; I2 = 94.99%) in COVID-19 patients admitted to non-ICU
See this image and copyright information in PMC

Comment on

References

    1. Shah A, Frost JN, Aaron L, Donovan K, Drakesmith H, Collaborators Systemic hypoferremia and severity of hypoxemic respiratory failure in COVID-19. Crit Care. 2020;24:320. doi: 10.1186/s13054-020-03051-w. - DOI - PMC - PubMed
    1. Pesavento R, Ceccato D, Pasquetto G, et al. The hazard of (sub)therapeutic doses of anticoagulants in non-critically ill patients with Covid-19: the Padua province experience. J Thromb Haemost. 2020 doi: 10.1111/jth.15022. - DOI - PMC - PubMed
    1. Hekimian G, Lebreton G, Brechot N, Luyt CE, Schmidt M, Combes A. Severe pulmonary embolism in COVID-19 patients: a call for increased awareness. Crit Care. 2020;24:274. doi: 10.1186/s13054-020-02931-5. - DOI - PMC - PubMed
    1. Fang C, Garzillo G, Batohi B, et al. Extent of pulmonary thromboembolic disease in patients with COVID-19 on CT: relationship with pulmonary parenchymal disease. Clin Radiol. 2020 doi: 10.1016/j.crad.2020.07.002. - DOI - PMC - PubMed
    1. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557–560. doi: 10.1136/bmj.327.7414.557. - DOI - PMC - PubMed